Spectrum Labs Hyposensitization Solution for allergic disease provides gold-standard treatment options for clients.
Spectrum Labs Hyposensitization Solution is a safe and effective alternative treatment option for allergic disease as compared with suppression or comfort therapies (eg, steroids, antihistamines, cyclosporine, antipruritics), which provide some relief to patients suffering from allergies but can be costly, commonly have side effects, and may have side effects with long-term use that are yet unknown. Spectrum Labs allergy treatment is capable of accommodating up to 20 allergens in a single set, with treatment lasting up to 9 months and success rates as high as 90%—all at 1 low price.
Two forms of Spectrum Labs Hyposensitization Solution are currently offered: subcutaneous injections and sublingual drops.
Subcutaneous injections allow patients to develop immunity to specific allergens following a positive allergy test; this results in diminished or absent immune response. Injections provide successful treatment for approximately 65% of patients1 and are administered over a 9-month period in increasing doses as well as increasing concentrations. This initial hyposensitization period is followed by monthly maintenance injections to maintain the pet’s increased tolerance to allergens. Injections may take several months to become effective but can be continued safely throughout the patient’s life.
Sublingual drops are a great solution for clients who prefer a needle-free option and for clients with dogs that have “failed injection immunotherapy due to lack of efficacy, adverse reactions, or compliance difficulties.”2 Unlike injectable therapy, daily administration is required; therefore, compliance may be a concern. Although drops may be easier for some pets and clients, they can be costlier than injections over the patient’s lifespan, and response time may be shorter.1
WHAT IS THE GOAL OF HYPOSENSITIZATION THERAPY?
Allergen-specific IgE serology and intradermal tests have become widely used to diagnose allergies and are both sensitive and specific.3 The ultimate goal of hyposensitization therapy is to restore or increase tolerance to the offending allergen by reducing IgE production. Hyposensitization therapy aims to reprogram the immune system to prevent overreaction to the specific allergens that cause problems for the pet.
For more information, visit VetAllergy.com/INNOVAT10NS.
- Spectrum Labs. http://www.vetallergy.com/vet. Accessed September 1, 2017.
- DeBoer D, Morris M. Multicentre open trial demonstrates efficacy of sublingual immunotherapy in canine atopic dermatitis (abstract). Vet Dermatol. 2012;23(Suppl 1):65.
- Mueller RS, Burrows A, Tsohalis J. Comparison of intradermal testing and serum testing for allergen-specific IgE using monoclonal IgE antibodies in 84 atopic dogs. Aust Vet J. 1999;77(5):290-294.
Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.